Literature DB >> 11404371

Agonistic and antagonistic activities of chemokines.

P Loetscher1, I Clark-Lewis.   

Abstract

Since the discovery of interleukin-8, about 50 chemokines have been identified and characterized. Originally, they were considered as inducible mediators of inflammation, but in recent years, several chemokines were identified that are expressed constitutively and function in physiological traffic and homing of leukocyte-lymphocytes in particular. All chemokines act via seven-transmembrane domain, G protein-coupled receptors. Eighteen such receptors have been identified so far. Studies on structure-activity relationships indicate that chemokines have two main sites of interaction with their receptors, the flexible NH2-terminal region and the conformationally rigid loop that follows the second cysteine. Chemokines are thought to dock onto receptors by means of the loop region, and this contact is believed to facilitate the binding of the NH2-terminal region that results in receptor activation. These studies have also highlighted the importance of the NH2-terminal region for agonistic and antagonistic activity. Recently, we have shown that some naturally occurring chemokines can function as receptor antagonists. These observations suggest a new mechanism for the regulation of leukocyte recruitment during inflammatory and immune reactions, which are based on the combination of agonistic and antagonistic effects.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11404371

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  22 in total

1.  Thermodynamic characterization of interleukin-8 monomer binding to CXCR1 receptor N-terminal domain.

Authors:  Harshica Fernando; Gregg T Nagle; Krishna Rajarathnam
Journal:  FEBS J       Date:  2007-01       Impact factor: 5.542

Review 2.  Chemokines and their receptors as potential targets for the treatment of asthma.

Authors:  C Palmqvist; A J Wardlaw; P Bradding
Journal:  Br J Pharmacol       Date:  2007-04-30       Impact factor: 8.739

3.  Role for the conserved N-terminal cysteines in the anti-chemokine activities by the chemokine-like protein MC148R1 encoded by Molluscum contagiosum virus.

Authors:  Qingwen Jin; Jeffrey D Altenburg; Mohammad M Hossain; Ghalib Alkhatib
Journal:  Virology       Date:  2011-07-28       Impact factor: 3.616

Review 4.  Chemokine oligomerization and interactions with receptors and glycosaminoglycans: the role of structural dynamics in function.

Authors:  C L Salanga; T M Handel
Journal:  Exp Cell Res       Date:  2011-01-09       Impact factor: 3.905

5.  The involvement of CXCL11 in bone marrow-derived mesenchymal stem cell migration through human brain microvascular endothelial cells.

Authors:  Yu Feng; Hong-Mei Yu; De-Shu Shang; Wen-Gang Fang; Zhi-Yi He; Yu-Hua Chen
Journal:  Neurochem Res       Date:  2014-02-14       Impact factor: 3.996

6.  Characterization of the chemokine CXCL11-heparin interaction suggests two different affinities for glycosaminoglycans.

Authors:  India C Severin; Jean-Philippe Gaudry; Zoë Johnson; Andreas Kungl; Ariane Jansma; Bernd Gesslbauer; Barbara Mulloy; Christine Power; Amanda E I Proudfoot; Tracy Handel
Journal:  J Biol Chem       Date:  2010-04-02       Impact factor: 5.157

7.  The emerging role of CXCL10 in cancer (Review).

Authors:  Mingli Liu; Shanchun Guo; Jonathan K Stiles
Journal:  Oncol Lett       Date:  2011-05-09       Impact factor: 2.967

8.  Dengue virus induces novel changes in gene expression of human umbilical vein endothelial cells.

Authors:  Rajas V Warke; Kris Xhaja; Katherine J Martin; Marcia F Fournier; Sunil K Shaw; Nathaly Brizuela; Norma de Bosch; David Lapointe; Francis A Ennis; Alan L Rothman; Irene Bosch
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  NMR structure of CXCR3 binding chemokine CXCL11 (ITAC).

Authors:  Valerie Booth; Ian Clark-Lewis; Brian D Sykes
Journal:  Protein Sci       Date:  2004-08       Impact factor: 6.725

Review 10.  Chemokines: role in inflammation and immune surveillance.

Authors:  B Moser; K Willimann
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.